Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

264 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rationale and design of the OPTIMIZE trial: OPen label multicenter randomized trial comparing standard IMmunosuppression with tacrolimus and mycophenolate mofetil with a low exposure tacrolimus regimen In combination with everolimus in de novo renal transplantation in Elderly patients.
de Boer SE, Sanders JSF, Bemelman FJ, Betjes MGH, Burgerhof JGM, Hilbrands L, Kuypers D, van Munster BC, Nurmohamed SA, de Vries APJ, van Zuilen AD, Hesselink DA, Berger SP. de Boer SE, et al. Among authors: hesselink da. BMC Nephrol. 2021 Jun 2;22(1):208. doi: 10.1186/s12882-021-02409-8. BMC Nephrol. 2021. PMID: 34078323 Free PMC article.
The use of cyclosporine in renal transplantation.
Hesselink DA, Smak Gregoor PJ, Weimar W. Hesselink DA, et al. Transplant Proc. 2004 Mar;36(2 Suppl):99S-106S. doi: 10.1016/j.transproceed.2003.12.047. Transplant Proc. 2004. PMID: 15041316 Review.
The effects of renal transplantation on circulating dendritic cells.
Hesselink DA, Vaessen LM, Hop WC, Schoordijk W, Ijzermans JN, Baan CC, Weimar W. Hesselink DA, et al. Clin Exp Immunol. 2005 May;140(2):384-93. doi: 10.1111/j.1365-2249.2005.02755.x. Clin Exp Immunol. 2005. PMID: 15807866 Free PMC article.
Tacrolimus predose concentrations do not predict the risk of acute rejection after renal transplantation: a pooled analysis from three randomized-controlled clinical trials(†).
Bouamar R, Shuker N, Hesselink DA, Weimar W, Ekberg H, Kaplan B, Bernasconi C, van Gelder T. Bouamar R, et al. Among authors: hesselink da. Am J Transplant. 2013 May;13(5):1253-61. doi: 10.1111/ajt.12191. Epub 2013 Mar 8. Am J Transplant. 2013. PMID: 23480233 Free article. Clinical Trial.
Follicular T helper cells and humoral reactivity in kidney transplant patients.
de Graav GN, Dieterich M, Hesselink DA, Boer K, Clahsen-van Groningen MC, Kraaijeveld R, Litjens NH, Bouamar R, Vanderlocht J, Tilanus M, Houba I, Boonstra A, Roelen DL, Claas FH, Betjes MG, Weimar W, Baan CC. de Graav GN, et al. Among authors: hesselink da. Clin Exp Immunol. 2015 May;180(2):329-40. doi: 10.1111/cei.12576. Clin Exp Immunol. 2015. PMID: 25557528 Free PMC article. Clinical Trial.
A Randomized Controlled Trial Comparing the Efficacy of Cyp3a5 Genotype-Based With Body-Weight-Based Tacrolimus Dosing After Living Donor Kidney Transplantation.
Shuker N, Bouamar R, van Schaik RH, Clahsen-van Groningen MC, Damman J, Baan CC, van de Wetering J, Rowshani AT, Weimar W, van Gelder T, Hesselink DA. Shuker N, et al. Among authors: hesselink da. Am J Transplant. 2016 Jul;16(7):2085-96. doi: 10.1111/ajt.13691. Epub 2016 Feb 26. Am J Transplant. 2016. PMID: 26714287 Free article. Clinical Trial.
264 results